Lessee, Operating Lease, Liability, to be Paid, Year One of Enlivex Therapeutics Ltd. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: Enlivex Therapeutics Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD history and change rate from 31 Dec 2022 to 30 Jun 2025.
Enlivex Therapeutics Ltd. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 30 Jun 2025 was $170,000, a 52% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

Enlivex Therapeutics Ltd. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$170,000	-$185,000	-52%	30 Jun 2025	6-K	29 Aug 2025	2025	Q2
Q4 2024	$275,000	-$135,000	-33%	31 Dec 2024	20-F	30 Apr 2025	2024	FY
Q2 2024	$355,000			30 Jun 2024	6-K	30 Aug 2024	2024	Q2
Q4 2023	$410,000	-$378,000	-48%	31 Dec 2023	20-F	30 Apr 2024	2023	FY
Q4 2022	$788,000			31 Dec 2022	20-F	10 Apr 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.